33 related articles for article (PubMed ID: 23485955)
1. A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder.
Wang G; McIntyre A; Earley WR; Raines SR; Eriksson H
Neuropsychiatr Dis Treat; 2014; 10():201-16. PubMed ID: 24511235
[TBL] [Abstract][Full Text] [Related]
2. Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.
McIntyre RS; Gorwood P; Thase ME; Liss C; Desai D; Chen J; Bauer M
J Clin Psychopharmacol; 2015 Dec; 35(6):706-10. PubMed ID: 26474010
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder.
Wang G; McIntyre A; Earley WR; Raines S; Eriksson H
Psychopharmacol Bull; 2012 Feb; 45(1):5-30. PubMed ID: 27738365
[TBL] [Abstract][Full Text] [Related]
4. Heavy Alcohol Drinking Associated Akathisia and Management with Quetiapine XR in Alcohol Dependent Patients.
Kurlawala Z; Vatsalya V
J Addict; 2016; 2016():6028971. PubMed ID: 27847671
[TBL] [Abstract][Full Text] [Related]
5. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.
Zhou X; Keitner GI; Qin B; Ravindran AV; Bauer M; Del Giovane C; Zhao J; Liu Y; Fang Y; Zhang Y; Xie P
Int J Neuropsychopharmacol; 2015 May; 18(11):pyv060. PubMed ID: 26012350
[TBL] [Abstract][Full Text] [Related]
6. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
[TBL] [Abstract][Full Text] [Related]
7. Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services.
Paton C; Anderson IM; Cowen PJ; Delgado O; Barnes TRE
Ther Adv Psychopharmacol; 2020; 10():2045125320930492. PubMed ID: 32595931
[TBL] [Abstract][Full Text] [Related]
8. Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics.
de Sousa RT; Zanetti MV; Brunoni AR; Machado-Vieira R
Curr Neuropharmacol; 2015; 13(5):616-35. PubMed ID: 26467411
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
[TBL] [Abstract][Full Text] [Related]
10. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.
Thase ME; Montgomery S; Papakostas GI; Bauer M; Trivedi MH; Svedsäter H; Locklear JC; Gustafsson U; Datto C; Eriksson H
Int Clin Psychopharmacol; 2013 May; 28(3):113-20. PubMed ID: 23485955
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
